Hyperfine stock reports 45 percent revenue growth

Published on 09/23/2026 at 21:05 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Hyperfine stock trades at USD 0.81 on September 23, 2026, with a 52-week low of USD 0.75. Q2 revenue reached USD 3.90 million and fiscal 2026 guidance stands at USD 20 million to USD 22 million.

Hyperfine stock, medical devices, revenue growth, Nasdaq, portable MRI, Illustration mit AI erstellt.

Hyperfine stock (ISIN US44916K1060) was trading at USD 0.81 on Nasdaq on September 23, 2026, compared with a 52-week low of USD 0.75. The medical-device company reported 45 percent year-over-year revenue growth in the second quarter, giving investors a clear operating metric alongside a share price near its yearly floor.

Revenue grows but misses estimates

Hyperfine generated USD 3.90 million in Q2 2026 revenue, up 45 percent from the prior-year period, according to Investing.com. The figure was below the USD 4.13 million analyst estimate, while the adjusted loss of USD 0.09 per share matched expectations.

The comparison matters because growth and execution are moving in different directions. Revenue expanded by USD 1.20 million from the prior-year quarter, but the quarterly loss still limits the immediate earnings contribution from the Swoop portable MRI system.

Guidance holds at USD 22 million

Hyperfine reiterated fiscal 2026 revenue guidance of USD 20 million to USD 22 million after the second-quarter results, Investing.com reported on September 14, 2026. The range places the annual target above the USD 13.56 million reported for fiscal 2025, although the two figures cover different reporting periods and should not be treated as a forecast achievement.

BTIG maintained a Buy rating and a USD 2.00 price target on September 22, 2026, according to MarketBeat. That target is USD 1.19 above the September 23 intraday price, making the analyst view materially different from the market quotation.

Nasdaq compliance adds pressure

Hyperfine received a Nasdaq notice on September 17, 2026, after its Class A stock closed below USD 1.00 for 30 consecutive business days, according to StockTitan. The notice places the USD 1.00 threshold beside the current USD 0.81 quotation and gives the stock a distinct listing-compliance issue in addition to its revenue and loss profile.

Stock stays near yearly low

Hyperfine stock was trading at USD 0.81 on Nasdaq at 3:03 p.m. ET on September 23, 2026. Its 52-week range was USD 0.75 to USD 2.22, while market capitalization stood at USD 68.05 million on the same date.